Mirum Pharmaceuticals, Inc. (MIRM)
97.93
-0.97
(-0.98%)
USD |
NASDAQ |
May 27, 15:01
Mirum Pharmaceuticals Cash from Investing (Quarterly) : -11.57M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 725.53M |
| Ionis Pharmaceuticals, Inc. | 536.82M |
| AnaptysBio, Inc. | 34.98M |
| BridgeBio Pharma, Inc. | -42.74M |
| ACADIA Pharmaceuticals, Inc. | 66.28M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -228.76M |
| Cash from Financing (Quarterly) | 270.08M |
| Free Cash Flow | -182.55M |
| Free Cash Flow Per Share (Quarterly) | -4.068 |
| Free Cash Flow to Equity (Quarterly) | -243.75M |
| Free Cash Flow to Firm (Quarterly) | -235.81M |
| Free Cash Flow Yield | -3.43% |